Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer

The majority of previous studies of lobaplatin in small cell lung cancer (SCLC) are small phase I–II studies. The present study aimed to verify the non-inferiority (in terms of efficacy) of lobaplatin plus etoposide (EL) vs. cisplatin plus etoposide (EP) in patients with previously untreated extensi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Cheng, Ying, Fan, Yun, Liu, Xiaoqing, Liu, Yunpeng, Liu, Jiwei, Wang, Dong, Yu, Yan, Qin, Shukui, Liu, Wei, Huang, Cheng, Zhang, Helong, Liang, Jun, Shi, Jianhua, Sheng, Lijun, Yu, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447897/
https://ncbi.nlm.nih.gov/pubmed/30988825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados